Skip to search formSkip to main contentSkip to account menu

Atovaquone

Known as: 3-(4-(4-chlorophenyl)cyclohexyl)-4-hydroxy-naphthalene-1,2-dione, 2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone, 2-(4-(4'-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone 
A synthetic hydroxynaphthoquinone with antiprotozoal activity. Atovoquone blocks the mitochondrial electron transport at complex III of the… 
National Institutes of Health

Related topics

Related topics

30 relations

Narrower (6)

566C566C80Atovaquone / ProguanilBW-566C

Broader (6)

Anti-Infective AgentsAntifungal AgentsAntimalarialsAntiparasitic Agents
Antiprotozoal AgentsAtovaquone 150 MG/ML Oral Suspension [Mepron]Atovaquone 250 MG / proguanil hydrochloride 100 MG Oral TabletAtovaquone 62.5 MG / proguanil hydrochloride 25 MG Oral Tablet [Malarone]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Antimalarial chemoprophylaxis and the risk of neuropsychiatric disorders.
2010
2010
Computer-assisted design of pro-drugs for antimalarial atovaquone.
Density Functional Theory (DFT) and ab initio calculation results for the proton transfer reaction in Kirby's enzyme models 1-6… 
2010
2010
Does atovaquone prolong the disease-free interval of toxoplasmic retinochoroiditis?
BackgroundTo evaluate the efficacy of suppressing a recurrence of Toxoplasma retinochoroiditis after treatment with atovaquone… 
2005
2005
Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.
BACKGROUND Trimethoprim-sulfamethoxazole (TMP-SMZ) has been used extensively for the prevention of Pneumocystis carinii (also… 
2004
2004
Failure of low-dose atovaquone prophylaxis against Pneumocystis jiroveci infection in transplant recipients.
Trimethoprim-sulfamethoxazole is the preferred agent for prophylaxis against Pneumocystis jiroveci pneumonia. Alternative agents… 
Highly Cited
2003
Highly Cited
2003
Recapitulation in Saccharomyces cerevisiae of Cytochrome b Mutations Conferring Resistance to Atovaquone in Pneumocystis jiroveci
ABSTRACT Pneumocystis jiroveci (human-derived P. carinii) is an opportunistic pathogenic fungus which causes pneumonia and is… 
2002
2002
The future outlook of antimalarial drugs and recent work on the treatment of malaria.
Highly Cited
2001
Highly Cited
2001
Pneumocystis carinii cytochrome b mutations are associated with atovaquone exposure in patients with AIDS.
This retrospective cohort study was conducted to determine whether Pneumocystis carinii cytochrome b gene mutations in patients… 
2000
2000
Effects of Atovaquone and Diospyrin-Based Drugs on the Cellular ATP of Pneumocystis carinii f. sp.carinii
ABSTRACT Atovaquone (also called Mepron, or 566C80) is a napthoquinone used for the treatment of infections caused by pathogens… 
Review
1993
Review
1993
Pneumocystis carinii pneumonia in cancer patients.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)